title: [Certain possible complications and side effects after the introduction of interleukin-2 in the scheme of treatment of surgical patients].
authors.forename: I V
authors.initials: IV
authors.lastname: Maĭborodin
authors.forename: A I
authors.initials: AI
authors.lastname: Shevela
authors.forename: D V
authors.initials: DV
authors.lastname: Egorov
authors.forename: E I
authors.initials: EI
authors.lastname: Strel'tsova
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004333:Drug Administration Routes; D004342:Drug Hypersensitivity; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D013530:Surgical Wound Infection / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins